ParaZero Expands European Market Footprint with Follow-On Order for SafeAir M4 Systems

TEL AVIV, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the 'company' or 'ParaZero'), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense counter-UAS systems, recently announced a follow-on purchase order for its innovative SafeAir™ M4 parachute recovery system from a prominent drone technology partner in Europe.
This order reflects ParaZero's growing traction in Europe's dynamic drone market, a hub for advanced unmanned aerial systems (UAS) in logistics, infrastructure inspection, and public safety. The expanding adoption of SafeAir™ M4 shows ParaZero's strengthening position as a trusted provider of mission-critical technologies supporting safe and compliant drone operations in regulated environments.The SafeAir™ M4, ParaZero's next-generation autonomous parachute recovery system, is designed for seamless integration with DJI's Matrice 4 series. It features real-time telemetry and is designed and expected to comply with the highest European regulatory standards to enable safe flight in urban areas throughout the EU.
The European partner, a key player in the region's commercial drone ecosystem, serves enterprise clients in precision agriculture, infrastructure inspection, and emergency response. This order reflects increasing demand for ParaZero's certified safety solutions in high-regulation markets, following the Company's recent CE Class C5 certification and other regulatory approvals for its SafeAir™ systems.
About ParaZero Technologies
ParaZero (Nasdaq: PRZO) is a leading developer of autonomous parachute safety systems technologies for commercial and military platforms as well as for urban air mobility (UAM) aircraft. Started in 2014 by a passionate group of aviation professionals and drone industry veterans, ParaZero develops and manufactures smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond-visual-line-of-sight (BVLOS) as well as for various military applications including Counter UAS. For more information about ParaZero, please visit https://parazero.com/
Forward-Looking Statements
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates' and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses how the SafeAir™ M4 is expected to comply with the highest European regulatory standards to enable safe flight in urban areas throughout the EU, the increasing demand for ParaZero's certified safety solutions in high-regulation markets, the expanding adoption of SafeAir™ M4 and the strengthening of ParaZero's position as a trusted provider of mission-critical technologies supporting safe and compliant drone operations in regulated environments. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ('SEC'), including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the SEC on March 21, 2024. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.
Investor Relations Contact:
Michal Efraty
Investor Relations
[email protected]
ParaZero Technologies Ltd. | 30 Dov Hoz, Kiryat Ono, Israel 5555626
P: +972-36885252 | E: [email protected] | F: +972-3-688-5246

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Washington Post

8 minutes ago

• Washington Post

The Latest: Trump muses about regime change in Iran after U.S. strikes on nuclear facilities

Israel's military said Monday it was striking around Iran's western city of Kermanshah, as fears of a wider regional conflict loomed large after the United States inserted itself into Israel's war by attacking Iranian nuclear sites . The operation raised urgent questions about what remained of Tehran's nuclear program and how its weakened military might respond. The price of oil rose as financial markets reacted.

Yahoo

10 minutes ago

• Yahoo

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /PRNewswire/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President of Yili Group, delivered a keynote speech titled "Innovating for a sustainable future" and shared Yili's latest innovative practices. On the opening day, the organizers unveiled the winners of the 2025 World Dairy Innovation Awards. Yili secured four World Dairy Innovation Awards and six commended Awards. Notably, Yili has claimed the World Dairy Innovation Awards for six consecutive years. Dr. Carolien van Loo, Head of Yili Innovation Center Europe, attended a roundtable forum on maternal and infant nutrition and breast milk research. Multiple star products from Yili's top infant formula brand, Pro-Kido, were featured as the Congress's officially designated products. At the Industry Leadership Forum, Dr. Ignatius Szeto systematically introduced Yili's global innovation practices across product innovation, maternal and infant nutrition, advanced dairy processing, and sustainable development. He emphasized: "Innovation is the driving force behind the sustainable prosperity of the dairy industry. Remaining consumer-centric, Yili dedicates itself to nutrition and health research across the full life cycle, keeps making core technological breakthroughs, and accelerates the commercialization of fundamental research outcomes—all of which contribute to the advancement of the global dairy sector." During the roundtable forum themed "Innovation in Pioneering a New Future for Global Maternal and Infant Health", Dr. Ignatius Szeto and Dr. Carolien van Loo engaged in in-depth discussions with experts including Jean-Christophe Kremer, Secretary-General of the International Special Dietary Foods Industries, and Richard Hall, Chair of FoodBev Media. The discussions focused on research about breast milk and maternal and infant nutrition. Dr. Carolien van Loo highlighted that Yili Innovation Center Europe, in collaboration with institutions such as Wageningen University and Donders Institute for Brain, Cognition and Behaviour, has conducted pioneering research on HMOs. Their breakthrough findings demonstrated HMOs' health benefits in enhancing immunity, protecting gut barrier function, preventing pathogen adhesion, and promoting cognitive development. The annual World Dairy Innovation Awards were announced at the event. This year, Yili Group secured four awards for its high-quality products and outstanding performance in innovation. Zhenlao Light Cream from Yijiahao Cheese won the Best Artisan Product, Joyday Crunchy Choco Lava was awarded Best Ice Cream, Yili's patented multi-enzymatic lactose-to-GOS technology: Boosting Gut Health in Qinghuo Adult Milk Powder claimed the Best Intolerance-Friendly Innovation, and Satine Carbon-Reduced Organic Milk won the Best CSR/Sustainability Initiative. Staying true to its philosophy of "No Innovation, No Future," Yili consistently increases its R&D investment to provide comprehensive nutrition solutions for consumers across the full life cycle. To date, Yili has established 15 innovation centers across Asia, Europe, and Oceania. Moving forward, Yili will continue to align its strategy with consumer needs, drive growth through technological innovation, and foster global partnerships to deliver enhanced health value for consumers worldwide, aiming to enable the sustainable prosperity of the dairy industry. View original content to download multimedia: SOURCE Yili Group Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Yahoo

10 minutes ago

• Yahoo

Undiscovered Gems in Europe for June 2025

As European markets navigate through a landscape marked by tensions in the Middle East and varying inflation pressures, the pan-European STOXX Europe 600 Index recently saw a decline of 1.54%, reflecting broader concerns impacting investor sentiment. Amid these challenges, discerning investors might find opportunities in small-cap stocks that demonstrate resilience and potential for growth, particularly those with strong fundamentals and innovative business models tailored to adapt to evolving economic conditions. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative 26.90% 4.14% 7.22% ★★★★★★ Martifer SGPS 102.88% -0.23% 7.16% ★★★★★★ Linc NA 101.28% 29.81% ★★★★★★ ABG Sundal Collier Holding 8.55% -4.14% -12.38% ★★★★★☆ Caisse Regionale de Credit Agricole Mutuel Toulouse 31 19.46% 0.47% 7.14% ★★★★★☆ Alantra Partners 3.79% -3.99% -23.83% ★★★★★☆ Dekpol 63.20% 11.06% 13.37% ★★★★★☆ Castellana Properties Socimi 53.49% 7.49% 44.78% ★★★★☆☆ Evergent Investments 5.39% 9.41% 21.17% ★★★★☆☆ Click here to see the full list of 336 stocks from our European Undiscovered Gems With Strong Fundamentals screener. Let's dive into some prime choices out of from the screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: Waberer's International Nyrt. offers transportation, forwarding, and logistics services across Europe and internationally, with a market cap of €218.85 million. Operations: The company generates revenue primarily from its insurance segment, which contributes €98.17 million. A notable financial aspect is the segment adjustment amounting to €659.39 million. Waberer's International Nyrt. has shown robust earnings growth of 38.6% over the past year, outperforming the transportation industry, which saw a -13.5% change. The company's net income for Q1 2025 was €7.5M, a significant jump from €1.1M in the previous year, reflecting improved profitability despite sales slightly decreasing to €194.4M from €196.7M last year. The debt-to-equity ratio rose to 62.6% over five years; however, interest payments remain well-covered by EBIT at 7.9x coverage and more cash than total debt suggests financial stability amidst these changes. Click to explore a detailed breakdown of our findings in Waberer's International Nyrt's health report. Examine Waberer's International Nyrt's past performance report to understand how it has performed in the past. Simply Wall St Value Rating: ★★★★★★ Overview: BTS Group AB (publ) is a professional services firm with a market capitalization of approximately SEK4.25 billion. Operations: The company generates revenue primarily from its BTS North America segment with SEK1.56 billion, followed by BTS Other Markets and BTS Europe at SEK838.95 million and SEK631.37 million respectively. Additionally, Advantage Performance Group contributes SEK142.19 million to the overall revenue stream. BTS Group, a smaller player in the professional services sector, has shown impressive earnings growth of 46% over the past year, outpacing the industry's 12%. Despite a large one-off gain of SEK167.5M affecting recent results, its debt-to-equity ratio improved slightly from 26.9% to 26.3% in five years. Trading at a significant discount of 57.5% below estimated fair value and having more cash than total debt enhances its appeal. However, net income for Q1 dropped to SEK25.73 million from SEK53.3 million last year, indicating potential volatility ahead despite revenue forecasts suggesting steady growth at about 6.7%. BTS Group's integration of AI technologies aims to enhance operational efficiency and diversify revenue streams; click here to explore the full narrative on the company's potential. Simply Wall St Value Rating: ★★★★★★ Overview: RaySearch Laboratories AB (publ) is a medical technology company that develops software solutions for cancer treatment globally, with a market cap of SEK10.78 billion. Operations: RaySearch Laboratories generates revenue primarily from its healthcare software segment, totaling SEK1.27 billion. It focuses on developing software solutions for cancer treatment worldwide. RaySearch Labs, a nimble player in medical technology, is making strides with its innovative software solutions for cancer treatment. The company has seen earnings soar by 122% over the past year, outpacing the healthcare services industry. With no debt on its books compared to a 24.9% debt-to-equity ratio five years ago, RaySearch stands financially robust. Recent upgrades to their RayStation and RayCare systems aim to streamline adaptive treatment planning through AI integration. However, challenges like exchange rate volatility and regulatory hurdles could impact growth despite projected annual revenue increases of 13.9%. RaySearch Laboratories is leveraging AI and new modules for potential growth. Click here to explore the full narrative on RaySearch's strategic advancements and market opportunities. Discover the full array of 336 European Undiscovered Gems With Strong Fundamentals right here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BST:3WB OM:BTS B and OM:RAY B. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@